2 recruiting, 2 unknown, 1 terminated. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Recruiting 2, Unknown 2, Terminated 1 |
Follow IgA Vasculitis: new trials by email Literature Review of IgA Vasculitis trials Research Report on IgA Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases Sparsentan - Focal Segmental Glomerulosclerosis, Minimal Change Disease | Phase 2 | Recruiting | Travere Therapeutics, Inc. | 67 | 2021-08-12 | 2026-05-12 |
| Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis Rituximab, Infliximab, Tocilizumab - Giant Cell Arteritis, Takayasu Arteritis | Phase 2 | Terminated | Cambridge University Hospitals NHS Foundation Trust | 22 | 2021-07-14 | 2025-06-17 |
| A Randomized Multicenter Study for Isolated Skin Vasculitis Colchicine, Dapsone, Azathioprine - Primary Cutaneous Vasculitis, Cutaneous Polyarteritis Nodosa | Phase 2 | Recruiting | University of Pennsylvania | 90 | 2017-01-01 | 2026-08-20 |
| The Research of Standard Diagnosis and Treatment for Severe HSP in Children Dexamethasone, Gamma globulin, Hemoperfusion - Henoch-Schoenlein Purpura | Phase 2 | Unknown | Nanjing Children's Hospital | 30 | 2015-08-01 | 2020-02-26 |
| Research on the Blood- Cooling - Toxin - Removing - Stasis - Dispersing Protocol Evaluation of Hench-schonlein Purpura Placebo, "ziying" granules - Purpura, Schoenlein-Henoch | Phase 2 | Unknown | Liaoning University of Traditional Chinese Medicine | 256 | 2009-11-01 | 2010-09-08 |
Cogan Syndrome (1) · Cryoglobulinemia, Familial Mixed (1) · Giant Cell Arteritis (1) · Glomerulonephritis, IGA (1) · Glomerulosclerosis, Focal Segmental (1) · Macular dystrophy, corneal type 1 (1) · Nephritis, Hereditary (1) · Nephrosis, Lipoid (1) · Polyarteritis Nodosa (1) · Polychondritis, Relapsing (1) · Recurrence (1) · Takayasu Arteritis (1) · Vasculitis (1)
Blood Coagulation Disorders (5) · Cardiovascular Diseases (5) · Hematologic Diseases (5) · Hemic and Lymphatic Diseases (5) · Hemorrhage (5) · Hemorrhagic Disorders (5) · Hemostatic Disorders (5) · Hypersensitivity (5) · Immune Complex Diseases (5) · Immune System Diseases (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Purpura (5) · Signs and Symptoms (5) · Skin Diseases (5)
Azathioprine (1) · Colchicine (1) · Dapsone (1) · Dexamethasone (1) · Hemoperfusion (1) · Infliximab (1) · Rituximab (1) · gamma-Globulins (1) · sparsentan (1) · tocilizumab (1)
Cambridge University Hospitals NHS Foundation Trust (1) · Liaoning University of Traditional Chinese Medicine (1) · Nanjing Children's Hospital (1) · Travere Therapeutics, Inc. (1) · University of Pennsylvania (1)
China (2) · United Kingdom (2) · United States (2) · Canada (1) · Germany (1) · Italy (1) · Japan (1) · Netherlands (1) · Poland (1) · Spain (1) · Sweden (1)
Aihua Zhang, M.D. (1) · Christian Pagnoux, MD, MPH, MSc (1) · David Jayne (1) · Radko Komers, MD, PhD (1) · Robert Micheletti, MD (1)
PMID 36853224, PMID 32345372, PMID 38724717, PMID 40938675, PMID 42384439
U54AR057319 (1)